STC1 and Kaposi's sarcoma: The apparent increased expression of STC1 within KS among patients with other concurrent KAD suggests that the tumor microenvironment in conjunction with systemic inflammation, and may contribute to the dissemination of advanced stage KS, which is observed in patients with KICS, MCD and/or PEL(43).